Rekvina Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/03/2026 ,inter alia, to consider and approve the proposal for issuance ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Rekvina Laboratories has informed BSE that its Board of Directors will meet on Monday, March 16, 2026. The key item on the agenda is to consider and approve a proposal for issuing equity shares or any other securities through a Preferential Issue, under the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The company has not disclosed the size, price, or potential investors for the proposed issue. Separately, the trading window for insiders has been closed and will remain so until 48 hours after the board meeting concludes.
If the preferential issue is approved, existing shareholders will face equity dilution. However, the company has not yet shared details on the issue size, pricing, or who the investors are, so the actual impact remains unclear until further announcements.